Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 8.738.635.795.754.70

What is the latest EV/Core EBITDA ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of LINCOLN PHARMACEUTICALS is 8.73 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20258.73
Mar20248.63
Mar20235.79
Mar20225.75
Mar20214.70

How is EV/Core EBITDA of LINCOLN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 8.73
1.16
Mar2024 8.63
49.05
Mar2023 5.79
0.70
Mar2022 5.75
22.34
Mar2021 4.7 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,272.7 Cr 2.8% 7.7% 14.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,236.0 Cr -1.8% -3.7% 17.2% Stock Analytics
DIVIS LABORATORIES ₹249,673.0 Cr 3.4% 10.1% 57.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,460.0 Cr 1.6% 0.8% 37.8% Stock Analytics
CIPLA ₹111,484.0 Cr -0.4% -5.6% -11.9% Stock Analytics
DR REDDYS LABORATORIES ₹95,220.3 Cr -1.1% -4.9% -9.9% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

2.8%

7.7%

14.3%

SENSEX

-1.6%

-4.2%

-7.2%


You may also like the below Video Courses